Nilo Therapeutics Launches With US$101 Million Series A Financing
New york city: Nilo Therapeutics, a biotechnology company, emerged from stealth today with a US$101 million Series A financing, aiming to revolutionise immunomodulation by targeting neural circuits that regulate the immune system. (US$1=RM4.21) According to BERNAMA News Agency, the financing